Centrum Medyczne Plejady Magdalena Celinska Loewenhoff Michal Zolnowski sp.k.

The gastroenterology department at Centrum Medyczne Plejady focuses on Inflammatory Bowel Disease, testing new therapeutic approaches aimed at achieving clinical remission and improving quality of life for patients.

• Crohn's disease – evaluation of novel biologics and small molecules
• Ulcerative colitis – assessment of induction and maintenance strategies
• Endoscopic response as a marker of treatment success
• Patient‑reported outcomes for disease activity

With a robust portfolio of 84 trials, the site collaborates with investigators to advance care for individuals living with chronic intestinal inflammation.

Research at the center targets autoimmune and systemic disorders, seeking to modulate immune pathways and reduce disease burden across a spectrum of conditions.

• Systemic lupus erythematosus – testing targeted immunomodulators
• Sjögren’s syndrome – improving glandular function and systemic symptoms
• Systemic sclerosis – evaluating antifibrotic agents
• Biomarker‑driven patient selection for personalized therapy

The department’s multidisciplinary team leverages its experience to explore long‑term safety and efficacy of emerging treatments.

The clinic conducts trials in dermatology to address inflammatory and chronic skin conditions, aiming to provide patients with more effective and tolerable options.

• Psoriatic arthritis – comparative studies of biologic agents
• Atopic dermatitis – long‑term safety of biologics in children
• Acne vulgaris – topical therapies for sustained clearance
• Chronic spontaneous urticaria – novel antihistamine‑refractory treatments

Participants benefit from state‑of‑the‑art assessments of disease activity and quality‑of‑life measures.

Investigations in the neurological field focus on migraine, Parkinson's disease, and epilepsy, evaluating new drugs and delivery methods to lessen symptom severity and improve daily functioning.

• Migraine – preventive and acute therapies for adolescents
• Parkinson's disease – agents targeting tremor and disease progression
• Dravet syndrome – adjunctive treatments to reduce seizure frequency
• Lennox‑Gastaut syndrome – combination therapies for refractory seizures

The site’s neurologic expertise supports rigorous safety monitoring and functional outcome assessments.

Trials address allergic rhinitis and related respiratory conditions, testing immunotherapy and symptom‑relief strategies for seasonal and perennial triggers.

• Birch pollen‑induced allergic rhinoconjunctivitis – sublingual immunotherapy efficacy
• Grass pollen allergy – pediatric safety and long‑term benefit
• Seasonal allergic rhinitis – quality‑of‑life impact
• H1 antihistamine‑refractory chronic urticaria – novel biologic options

By integrating allergen challenge models, the center contributes valuable data on disease control across age groups.

The facility also explores cardiovascular and metabolic health, aiming to lower risk factors and improve outcomes for patients with established disease.

• Atherosclerotic cardiovascular disease – LDL‑cholesterol lowering interventions
• Obesity – lifestyle‑adjunct pharmacologic studies
• Metabolic syndrome – combined therapy assessments
• Cardiovascular event reduction – long‑term safety monitoring

The research integrates cardiovascular endpoints with metabolic parameters to provide a comprehensive view of patient health.